Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer
- 1 March 2007
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 67 (4) , 995-1001
- https://doi.org/10.1016/j.ijrobp.2006.10.034
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancerInvestigational New Drugs, 2005
- Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II StudyJournal of Clinical Oncology, 2005
- Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancerAnnals of Oncology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Radiotherapy Patterns of Care Study in Lung CarcinomaJournal of Clinical Oncology, 2003
- Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive‐stage small cell lung carcinomaCancer, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the LungNew England Journal of Medicine, 1987
- Measuring the quality of life of cancer patientsJournal of Chronic Diseases, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958